HONG KONG – Wuxi Pharmatech Inc. is building a $150 million biologics manufacturing facility for subsidiary Wuxi Biologics – the largest of its kind in China. When finished, the new facility will put the company in a different league, multiplying its production capacity and doubling its client base.